Introduction
Proteins from the ever expanding Bcl-2 family have a major role in the regulation of cell death and cell survival. Anti-apoptotic members of the Bcl-2 family (in particular Bcl-2 and Bcl-XL) are potent oncoproteins, whereas pro-apoptotic Bcl-2 homologs (in particular Bax) has been shown to act as a tumor suppressors (Kroemer, 1997; Reed, 1997) . Although there is little doubt that Bcl-2/Bax-like molecules act at the level of mitochondria to regulate apoptosis ± Bcl-2 by stabilizing the mitochondrial membrane barrier function, Bax by favoring mitochondrial membrane permeabilization (MMP) ± the molecular mechanisms by which these proteins act on mitochondrial membranes are rather controversial Kroemer and Reed, 2000; Vander Heiden and Thompson, 1999; Zamzami et al., 1998) . When inserted into arti®cial membranes, both Bcl-2 and Bax can form ion channels, a property that may account for direct membrane permeabilization (by Bax) (Antonsson et al., 1997; Schendel et al., 1997) or for indirect membrane stabilization eects by charge compensation (by Bcl-2) (Minn et al., 1997; Vander Heiden et al., 2000) . Thus, according to one school of thought Bax and Bcl-2 would regulate apoptosis by virtue of their capacity to form autonomous ion channels (Antonsson et al., 1997; Minn et al., 1997; Schendel et al., 1997; Vander Heiden et al., 2000) . According to another group of authors, Bax and Bcl-2 may regulate MMP via interactions involving proteins from the so-called permeability transition pore complex (PTPC), a polyprotein ensemble built up in the contact site of the inner and outer mitochondrial membranes (Brenner et al., 2000a; JuÈ rgensmeier et al., 1998; Marzo et al., 1998a,b; Narita et al., 1998; Pastorino et al., 1998 Pastorino et al., 1999 Shimizu et al., 1999) . The PTPC contains the most abundant outer membrane (OM) protein voltage-dependent anion channel (VDAC), the most abundant inner membrane (IM) protein adenine nucleotide translocase (ANT), and the matrix protein cyclophilin D, the pharmacological target of cyclosporin A (CsA) within mitochondria (Crompton et al., 1998; Marzo et al., 1998b) . Indeed, CsA, the ANT ligand bongkrekic acid (BA), and the VDAC inhibitor KoÈ nig's polyanion (PA) have all been shown to prevent Bax-mediated MMP in isolated mitochondria (JuÈ rgensmeier et al., 1998; Marzo et al., 1998a; Narita et al., 1998; Shimizu et al., 1998) . Moreover, physical interactions between Bax or Bcl-2 and VDAC and ANT have been detected using the yeast-two-hybrid system and co-immunoprecipitation assays (Marzo et al., 1998a; Shimizu et al., 1999) . Bax has also been shown to increase pore formation in chemically de®ned model membranes containing either ANT or VDAC, while Bcl-2 prevents pore formation by ANT or VDAC (Brenner et al., 2000a; Marzo et al., 1998a; Shimizu et al., 1999 Shimizu et al., , 2000b .
Bid (21 kDa) is a pro-apoptotic protein which, as other members of the Bcl-2 family, can form autonomous ion channels, provided that has been processed to its mature form (Kudla et al., 2000; Schendel et al., 1997) . One particularity of Bid is that it can be cleaved by caspase-8, the caspase speci®cally activated by death receptors of the CD95/TNF-R/ TRAIL family. Cleavage of Bid results in removal of the N-terminus and the consequent generation of a truncated Bid variant (t-Bid, 15 kDa), t-Bid translocates from the cytosol to mitochondria, thereby favoring MMP and cell death Luo et al., 1998) . In addition, uncleaved Bid can also translocate to mitochondria, via a mechanism which is still elusive (Desagher et al., 1999) . The knock-out of Bid confers protection against the induction of hepatocyte cell death (but not against the induction of thymocyte apoptosis) by in vivo injection of an anti-CD95 antibody (Yin et al., 1999) , indicating that Bid constitutes an obligatory link between CD95-mediated signaling and apoptosis, at least in some cell types, the so-called`type-2' cells, in which death receptor activation only results into cell death when MMP is induced (Scadi et al., 1998 (Scadi et al., , 1999 . Several in vitro studies suggest that Bid can induce MMP in a fashion that is not inhibited by CsA or other PTPC blockers (Desagher et al., 1999; Eskes et al., 2000; Shimizu and Tsujimoto, 2000) . However, recent data indicate that treatment of cells or mice with CsA can prevent CD95-induced hepatocyte death (Feldmann et al., 2000; Hatano et al., 2000) . These data suggest that Bid and a CsA-inhibitable (PTPC-mediated?) step may both be involved in the same apoptosis-inducing signal transduction pathway.
Prompted by the above controversy, we decided to re-examine the question as to whether Bid induces MMP via a PTPC-dependent or PTPC-independent mechanism. In the present work, the membrane permeabilizing eects of Bid have been monitored in intact cells, in puri®ed mitochondria, in proteoliposomes containing reconstituted PTPC constituents, as well as in synthetic lipid bilayers containing puri®ed PTPC constituents. Our data suggest that Bid can exert at least some of its MMP-inducing eects via the PTPC.
Results

Microinjected Bid induces MMP and apoptosis via PTPC
When microinjected into the cytoplasm of Rat-1 ®broblasts, recombinant Bid or t-Bid induce a rapid (90 min) dissipation of the Dc m (detected by the potential-sensitive dye CMXRos, red¯uorescence), as well as nuclear chromatin condensation (detected by Hoechst 33342, blue¯uorescence) ( Figure 1a ). These eects of Bid or t-Bid are inhibited, both at the mitochondrial and at the nuclear levels, by three pharmacological agents acting on the PTPC, namely CsA, the non-immunosuppressive CsA derivative Nmethyl-4-Val-CsA (both ligands of mitochondrial cyclophilin D) and BA (an ANT ligand) (Figure 1a , b). These pharmacological data suggest that Bid and tBid induce apoptosis via a direct or indirect eect on the PTPC.
Bid causes MMP in isolated mitochondria via PTPC
To clarify whether Bid or t-Bid may directly aect the PTPC in a cell-free system, puri®ed mouse liver mitochondria were pretreated with CsA or shampretreated and then exposed to recombinant Bid or tBid, followed by immunoblot determination of the release of two soluble intermembrane proteins, AIF and Cyt-c. In the speci®c experimental setting that we have chosen, both Bid and t-Bid induce the release of AIF and Cyt-c in a CsA inhibitable fashion ( Figure  2a ). Of note, CsA also reduced the binding of biotinylated recombinant Bid to puri®ed mitochondria in vitro (Figure 2b ), concomitant with its inhibitory eect on the Cyt-c/AIF release. Pretreatment of mitochondria with KoÈ nig's polyanion (PA), a speci®c inhibitor of VDAC, also reduced the incorporation of Bid into mitochondrial membranes (Figure 2b ), suggesting that Bid interacts with proteins from the PTPC to aect the permeability of mitochondrial membranes.
Bid acts on PTPC constitutents reconstituted into liposomes
The PTPC puri®ed from rat brain can be reconstituted into proteoliposomes, followed by assessment of the release of hydrophilic indicator substances entrapped into the liposomal lumen (Brenner et al., 2000b; Costantini et al., 2000; Marzo et al., 1998b) . Addition of Bid or t-Bid to PTPC proteoliposomes causes a similar release of 4-methylumbelliferone phosphate (4-MUP) as does the speci®c ANT ligand Atr (Figure 3 ). This eect was strongly inhibited by both CsA and BA, suggesting that, in this particular experimental system, Bid and t-Bid do not aect membrane permeability in a non-speci®c fashion (via an action on lipids and/or formation of autonomous channels) and rather act through protein-protein interactions with proteins contained in the PTPC. Bax, which is contained in the PTPC, has been shown to interact with a motif of ANT (aa 105 ± 155) (Marzo et al., 1998a) , thereby facilitating membrane permeabilization induced by Atr. Two peptides derived from the Bax/ANT interaction domain (ANT104 ± 116, ANT117 ± 134) inhibited the eect of Bid on PTPC proteoliposomes ( Figure 4 ). In contrast, a scrambled version of ANT104 ± 116 and a peptide corresponding to the sixth transmembrane domain of ANT (ANT273 ± 291) had no such eect ( Figure 4 ). These data underline the likely eect of Bid on ANT and/or Bax contained within PTPC.
Bid effects on proteoliposomes containing ANT and Bax
It is known that Bax, one of the constituents of the PTPC, facilitates membrane permeabilization by Bid (Desagher et al., 1999) . Moreover, one of the major pore forming proteins contained in the PTPC is ANT, which in turn can physically and functionally interact with Bax (Brenner et al., 2000a; Costantini et al., 2000; Marzo et al., 1998b) . We therefore assessed the eect of Bid on proteoliposomes containing highly puri®ed ANT and/or recombinant Bax ( Figure 5 ). While Bid had no signi®cant eect on the permeability of proteoliposomes containing ANT or Bax alone, it did exert a major permeabilizing eect on proteoliposomes containing the combination of both ANT and Bax ( Figure 5 ). These data suggest cooperative membrane permeabilizing eects of Bid, Bax, and ANT within the PTPC.
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Cooperative channel formation by Bid, ANT, and Bax reconstituted into synthetic bilayers
To further substantiate the putative functional interaction of Bid with Bax and/or ANT, Bid or t-Bid were added to planar lipid bilayers assessed in tip-dip experiments for single channel conductances. In a large series of experiments (45 registrations per condition), it was found that low doses of Bid, which themselves do not cause channel formation, can provoke the formation of channels with discrete levels of conductance (*60 and 150 pS for Bid) in the presence of ANT ( Figure 6 ). As an internal control, addition of BA completely abolishes this cooperative eect. When added to synthetic bilayers containing ANT+Bax (which on their own do not form channels, ref. Brenner et al., 2000a and Figure 6) , induces the formation of one slowly opening channel whose conductance value is 340 pS with a rapidly¯ickering channel of 240 pS. After several seconds a second channel whose conductance value was 450 pS opened and the same 240 pS¯ickering channel was observed. Thus, the conductances of ANT+BAX+Bid are much larger than those observed for Bid added to mem- Buer only (Co, control), Bid (5 mM), or t-Bid (1 mM) were introduced into the cytoplasm of Rat-1 cells, which were cultured for 90 min in the absence or presence of 3 mM CsA, 3 mM N-Methyl-4-Val-CsA (mod. CsA), or 50 mM of BA (added 30 min before injection). Microinjected cells were identi®ed by addition of FITC-labeled dextran to the injection buer (green¯uorescence). Cells were stained with the Dc m -sensitive dye CMXRos (red¯uorescence) and the chromatin-speci®c¯uorochrome Hoechst 33342 (bluē uorescence). Images representative for the dominant phenotype (450% of cells) images are shown. (b) Quantitation of the nuclear and mitochondrial signs of apoptosis induced by micorinjected Bid and t-Bid. Micorinjections were carried out as in a. Data (X+s.e.m., n=3) were pooled from three independent experiments involving 100 ± 150 microinjected cells per data point branes containing either ANT alone or Bax alone. Slightly dierent results were obtained when Bid was replaced by t-Bid. t-Bid added to protein-free lipid bilayers ( Figure 6 ) or Bax-containing lipid bilayers (not shown) causes the generation of a low-conductance channel (*50 pS), irrespective of the presence of Bax. However, when added to membranes containing ANT (or ANT+Bax), t-Bid generates channels with a maximum conductance of *100 and 270 pS), again without detectable eects of Bax (not shown). Thus, at dierence with the liposome system, the more sensitive electrophysiological approach does not reveal a Figure 3 Eect of Bid and t-Bid on PTPC proteoliposomes. PTPC constituents were puri®ed from rat brain and reconstituted into liposomes loaded with 4-MUP. Liposomes were left untreated (control) or exposed to the indicated dose of Atr, Bid, or t-Bid, in the presence or absence of the two PTPC inhibitors CsA or BA. Then, alkaline phosphatase was added to obtain the transformation of liposome released 4-MUP into thē uorescent product 4-methylumbelliferone (4-MU). Results are means+s.e.m. for four dierent experiments Figure 4 Inhibitory eects of ANT-derived peptides on the PTPC. PTPC proteoliposomes were exposed to Bid or t-Bid protein preincubated in the presence or absence of synthetic peptides corresponding to the ®rst intermembrane loop (ANT104 ± 116) or to the adjacent third transmembrane helix (ANT117 ± 134) of ANT, as well as control peptides (scrambled ANT104 ± 116 and a peptide corresponding to the sixth transmembrane domain: ANT273 ± 291. Then, membrane permeabilization was assessed as in Figure 3 . Results are means +s.e.m., (n=3) Figure 5 Permeabilization of ANT-Bax proteoliposomes by Bid. Proteoliposomes containing ANT and/or Bax were loaded with 4-MUP, exposed to Atr, Bid or t-Bid, and the fraction of 4-MUP accessible to alkaline phosphatase was quantitated by measuring the 4-MU-dependent¯uorescence (X+s.e.m., n=3) stringent requirement of Bax to mediate t-Bid-induced membane permeabilization and/or channel formation. Altogether, these electrophysiological data indicate cooperative channel formation by Bid, Bax and ANT on the one hand and t-Bid+ANT on the other hand ( Figure 6 ).
Discussion
The results of this work suggest that, at least in particular experimental conditions, Bid can functionally interact with constituents of the PTPC. This is suggested by data obtained in four completely dierent experimental systems. First, in intact cells, microinjection of Bid causes mitochondrial and nuclear eects which are reduced by three dierent pharmacological PTPC inhibitors (Figure 1) . Second, Bid (and t-Bid) induce MMP when added to puri®ed mitochondria in a PTPC inhibitor-sensitive fashion (Figure 2 ). Third, low doses of Bid (and t-Bid) only permeabilize liposomal membranes if such membranes contain the semipuri®ed PTPC (Figure 3 ) or highly puri®ed ANT+Bax ( Figure 5 ). Fourth, single channel conductance measurements indicate a cooperative eect between Bid and ANT ( Figure 6 ). Apparently, these results are incompatible with the reported PTPC independence of Bid-mediated MMP (Desagher et al., 1999; Eskes et al., 2000; Kudla et al., 2000; Shimizu and Tsujimoto, 2000) . The present discussion is a tentative to reconcile these opposed interpretations.
In the past, several authors have disaggreed on the pro-apoptotic mode of action of Bax, a protein which presumably possesses a similar structure as Bid. Does Bax act on the PTPC to induce MMP or does it act independently from PTPC? When microinjected into cells, the pro-apoptotic eect of Bax can be inhibited by CsA, N-methyl-4-Val-CsA, and BA (Marzo et al., 1998a) , both at the mitochondrial and the nuclear levels, much as this has been observed for Bid (this study). Similarly, rapid overexpression of Bax under the control of the ecdyson promoter induces a type of cell death which is eciently blocked by a combination of CsA and aristolochic acid (a phospholipase A2 inhibitor) (Pastorino et al., 1998) thought to synergistically act on the PTPC (Zoratti and SzaboÁ , 1995) . In contrast, transient overexpression of Bax can kill COS cells in a way that is not controlled by CsA and/or aristolochic acid (Eskes et al., 1998) . Four dierent groups have reported that Bax, when added to puri®ed mitochondria, causes Cyt-c release and Dc m dissipation and that this eect is suppressed by the PTPC inhibitors CsA, N-methyl-4-Val-CsA, and BA (JuÈ rgensmeier et al., 1998; Marzo et al., 1998a; Narita et al., Pastorino et al., 1999) . Low doses of Bax only permeabilizes OM, whereas higher doses synchronously permeabilize IM and OM, and in both cases CsA inhibits MMP (Pastorino et al., 1999) . In contrast, in the presence of relatively high doses of MgCl 2 (4 mM), a PTPC inhibitor (Bernardi et al., 1993) , Bax can permeabilize membranes of puri®ed mitochondria in vitro without that CsA or BA would inhibit this reaction (Eskes et al., 1998) .
Bax has been reported to physically interact with two PTPC constituents, namely ANT (by co-immunoprecipitation and yeast-two-hybrid screening) (Marzo et al., 1998a) and VDAC (by co-immunoprecipitation) (Shimizu et al., 1999) . Yeast cells in which the three ANT isoenzymes have been inactivated by homologous recombination are relatively resistant against killing by Bax (Marzo et al., 1998a) . Inactivation of the ANT isoenzyme 2 alone suces to render yeast cells resistant to Bax (Harris et al., 2000) (but see ref. Priault et al., 1999a) . In contrast, VDAC appears to be dispensable for Bax-mediated killing of yeast (Gross et al., 2000; Harris et al., 2000; Priault et al., 1999b ), yet may be important for mediating the Bax-induced release of cytochrome c (Shimizu et al., 1999) . When added to plain (protein-free) phosphatidylserine/phosphatidylcholine/cholsterol liposomes (2 : 2 : 1, w : w), recombinant Bax induces the release of carboxy¯uorescein (Antonsson et al., 1997) . In contrast, in liposomes having a dierent lipid composition (phosphatidylcholine/cardiolipin 45 : 1, w : w), Bax only causes membrane permeabilization in the presence of ANT, yet has no eect on its own (Marzo et al., 1998a) . When tested on planar lipid membranes, high doses of Bax (4100 nM) either form non-speci®c channels with conductances up to 2 nS (Antonsson et al., 1997; Brenner et al., 2000a; Schlesinger et al., 1997; Shimizu et al., 2000b) or non-speci®cally destabilize the membrane by diminishing its surface tension (BasanÄ ez et al., 1999) . However, at lower doses (1 nM), Bax only acts on membranes also containing the PTPC constituent ANT (Brenner et al., 2000a) . Bax has also been reported to interact with VDAC to create a giant cytochrome c-permeable pore in arti®cial membranes (Shimizu et al., 2000a) . Altogether, this data suggest two dierent actions of Bax, one`non-speci®c' eect on lipid bilayers, and a`speci®c' one involving interactions with proteins from the PTPC.
In contrast to Bax, Bid (or t-Bid) has been unanimously viewed as a protein causing`non-speci®c' membrane eects, when overexpressed in cells, although some discrepancies have been reported. Transient overexpression of Bid was reported to cause the release of cytochrome c without Shimizu and Tsujimoto, 2000) or with (Luo et al., 1998 ) Dc m loss, respectively. When added to puri®ed mitochondria, Bid was found to release cytochrome c without aecting the Dc m , and cytochrome c translocation was not aected by CsA or BA (Desagher et al., 1999; Eskes et al., 2000; Shimizu and Tsujimoto, 2000) . It has to be mentioned that these in vitro eects were observed either in a MgCl 2 -rich buer (Desagher et al., 1999; Eskes et al., 2000) or at Bid doses at least ®ve times higher (Shimizu and Tsujimoto, 2000) than those used in our study, suggesting that dierences in the experimental conditions (buer, protein concentration, origin of mitochondria etc.) may account for these discrepancies. Paradoxically enough, a peptide corresponding to the BH3 domain of Bid (which is required for Bid-induced MMP; ref. Desagher et al., 1999; Luo et al., 1998) , can itself cause MMP in puri®ed mitochondria, yet this eect is inhibited by CsA and Bcl-2 (Shimizu and Tsujimoto, 2000) . Moreover, transfection with a novel ANT-targeted viral apoptosis inhibitor (UL37 from cytomegalovirus) prevents the tBid-mediated cytochrome c release of aCD95-stimylated HeLa cells (Goldmacher et al., 1999) , supporting the idea that tBid must act on ANT to induce apoptosis. In a more arti®cial system, when tested on synthetic membranes, recombinant tBid alone can form non-speci®c channels (80 pS) and permeabilize liposomes to KCl (Schendel et al., 1999) and carboxy¯uorescein (Kudla et al., 2000) . Again, these eects were observed in conditions dierent from those employed in the present study, using a dierent set of lipids and/or much higher concentrations of tBid (Kudla et al., 2000; Schendel et al., 1999) .
As a result, the heterogeneity of data obtained with Bid/t-Bid is reminescent of that obtained with Bax. Perhaps this is not surprising, given the strong structural similarity between Bid and other members of the Bcl-2/Bax family (Chou et al., 1999; McDonnell et al., 1999) . Bid has been suggested to act on Bax, favoring its insertion into the mitochondrial OM and/ or its oligomerization, thereby giving rise to the formation of protein-permeant pores (Desagher et al., 1999; Eskes et al., 2000) . If Bax is truly the downstream target of Bid, then Bid is likely to act as Bax, either via`non-speci®c' or`speci®c' eects. Which parameters would then determine whether PTPCdependent or PTPC-independent Bid/Bax eects dominate? Although this question requires further experimental exploration, it is tempting to speculate that dierences in the abundance of interacting proteins (Bid, Bax, VDAC, ANT etc.), as well as dierences in the speci®c lipid environment (concentration of acidic phospholipid, pH, microdomains) may play a critical role in tipping the balance to a`non-speci®c' or speci®c' mode of MMP induction. Whatever will be the explanation, based on the data reported in this study, it would be an oversimpli®cation to assume that Bid acts always in a PTPC-independent fashion.
Materials and methods
Microinjection
Rat-1 ®broblasts cells were microinjected with PBS (pH 7.2) containing FITC-labeled dextran 7000 (5 mg/ml; Sigma), recombinant Bid or t-Bid (100 mM, produced and puri®ed as described in references Desagher et al., 1999; Eskes et al., 2000) into the cytoplasm (injection pressure 150 hPa, compensation pressure 50 hPa, time of injection 0.2 S. Cyclosporin A (CsA; 3 mM; Sigma), N-methyl4-Val-cyclosporin A (3 mM; kindly provided by Dr Roland Wenger (Sandoz AG, Basel, Switzerland)) and bongkrekic acid (BA, 50 mM; kindly provided by Dr Duine (Delft University, Netherlands)) were added to the culture medium 30 min before microinjection. After microinjection, cells were incubated for 90 min at 378C and stained with CMXRos (100 nM) and Hoechst 33342 (1 mM, Molecular Probes). At least 150 cells were microinjected in three independent sessions for each data point.
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In vitro assays involving isolated mitochondria Mitochondria were puri®ed from Balb/c mouse livers on a Percoll 1 gradient and were stored on ice in (300 mM sucrose, 200 mM EGTA, 5 mM TES-KOH pH 7.2) for up to 4 h. Mitochondria were exposed to recombinant Bid (5 nM) or t-Bid (1 nM) in the absence or presence of CsA (3 mM, added 15 min before) for 30 min at room temperature in (200 mM Sucrose, 5 mM succinate, 1 mM Pi, 10 mM EGTA, 2 mM rotenone, 10 mM Tris-MOPS, pH 7.4) followed by centrifugation (6800 g, 48C, 10 min) and immunodetection of AIF and cytochrome in the supernatant using published methods (Liu et al., 1996; Susin et al., 1999) . Mitochondria were also pre-incubated (20 min) with Koenig's polyanion (PA, 0.5 mg/ml; kind gift of Dieter Brdizcka, University of Konstanz, Germany), followed by washing (6800 g, 48C, 10 min), BA (50 mM) or CsA (3 mM) and then exposed to biotinylated Bid (600 ng/ml) for 30 min at 378C. Washed mitochondria (6800 g, 48C, 10 min; 26) were then subjected to SDS ± PAGE (2 mg protein/lane), Western bloting and detection of Bid retention using a neutralite avidin-horseradish peroxidase conjugate (Southern Biotechnology).
Biotinylation of Bid
Recombinant Bid (2 mg in 1 ml) was dialysed in 0.1 M sodium bicarbonate buer (pH 8) overnight at 48C. Recombinant Bid was then incubated in the presence of 0.1 M of fresh active biotin obtained by dissolving 1 mg of d-biotin-Nhydroxysuccimide-ester in 30 ml of dimethyl-formamide. Biotinylated Bid was dialysed over night in PBS buer. The biotinylated protein was aliquoted and stored at 7808C.
PTPC purification and reconstitution into liposomes
PTPC constituents were puri®ed and reconstituted into liposomes as previously shown (Brenner et al., 2000b; Marzo et al., 1998b) . Brie¯y, four Wistar rat brains (3 ± 4 month-old males) were homogenized in 40 ml of buer 1 (1 mM amonothioglycerol, 10 mM glucose, pH 8.0) and centrifuged twice (15 min, 12 000 g, 48C). The pellets were resuspended in buer 1+0.5% Triton X-100 (Boehringer Manheim, Mannheim, Germany) for 30 min at room temperature (RT) while stirring. The Triton-soluble protein fraction obtained by ultracentrifugation (40 min, 50 000 g, 48C) was mixed with 17 g DE52 resin previously equilibrated with buer 2 (1.5 mM NaH 2 PO 4 , 1.5 mM KH 2 PO 4 , 100 mM glucose, 1 mM dithiothreitol, pH 8.0). The resin was packed into an FPLC column (XK16/20; Pharmacia) and eluted with buer 2 supplemented with 50 mM KCl (buer 3) or 400 mM KCl (buer 4). After equilibration with buer 3 (0.8 ml/min, 6 ml), elution was performed on a linear gradient from 50 ± 400 mM KCl (buers 3 versus 4), followed by determination of hexokinase activity. Lipid vesicles were prepared by mixing 100 mg phosphatidylcholine and 20 mg cholesterol in 1 ml chloroform, evaporation of the chloroform under nitrogen, and resuspension in 1 ml liposome buer (125 mM sucrose+10 mM HEPES, pH 7.4)+0.3% n-octyl-b-D-pyranoside by vortexing (40 min, RT). One volume of liposomes was incubated with one volume of PTPC-containing fraction during 20 min at RT and dialysed overnight against liposome buer at 48C.
ANT purification and reconstitution in liposomes
ANT was puri®ed from rat heart mitochondria as previously described (Marzo et al., 1998a) . After mechanical shearing, mitochondria were suspended in buer A (220 mM mannitol, 70 mM sucrose, 10 mM HEPES (pH 7.4), 200 mM EDTA, 100 mM DTT, 0.5 mg/ml subtilisin), kept 8 min on ice and sedimented twice by dierential centrifugation (5 min, 500 g, and 10 min, 10 000 g). Mitochondrial proteins were solubilized by 6% [v : v] Triton X-100 (Boehringer Mannheim) in buer B (40 mM KH 2 PO 4 , 40 mM KCl, 2 mM EDTA, pH 6.0) for 6 min at room temperature and solubilized proteins were recovered by ultracentrifugation (30 min, 24 000 g, 48C). Then, 2 ml of this Triton X-100 extract was applied to a column ®lled with 1 g of hydroxyapatite (BioGel HTP, BioRad), eluted with buer B and diluted [v : v] with buer C (20 mM MES, 200 mM EDTA, 0.5% Triton X-100, pH 6.0). Subsequently, the sample was separated with a Hitrap SP column using a FPLC system (Pharmacia) and a linear NaCl gradient (0 ± 1 M). Puri®ed ANT (100 mg/ml) and/or Bax (20 mg/ml) were (co-)reconstitued in phosphatidyl/cardiolipin (45 : 1, w : w) liposomes.
Quantitation of liposomal permeabilization
PTPC-or ANT-proteoliposomes were sonicated in the presence of 4-umbelliferylphosphate (4-UMP, 1 mM, Sigma) and 10 mM KCl (50 W, 22 s, Branson soni®er 250) on ice and washed on Sephadex G-25 columns (PD-10, Pharmacia) (Costantini et al., 2000) . Twenty-®ve ml-aliquots of liposomes were mixed with various concentrations of pro-apoptotic inducers including atractyloside (200 mM) and Bid/t-Bid, incubated for 1 h at RT and diluted to 3 ml in 10 mM HEPES, 125 mM saccharose (pH 7.4). Inhibitors of mitochondrial membranes permeabilization, 10 mM CsA, 50 mM BA or ANT-ANT-2-derived peptides ANT104 ± 116 NH 2 -DRHKQFWRYFAGN-COOH; ANT117 ± 134 LASGGAA-GATSLCFVYPL, scrambled ANT104 ± 116 FQNYWGH-KRFRDA, ANT273 ± 291 GAWSNVLRGMGGAFVLVY were added to the liposomes 30 min before treatment. After addition of 10 ml alkaline phosphatase (5 U/ml, Boerhinger Mannheim; in liposome buer+0.5 mM MgCl 2 ), samples were incubated for 15 min at 378C. The enzymatic conversion of 4-UMP in 4-UM was stopped by addition of 150 ml 10 mM HEPES-NaOH, 200 mM EDTA (pH 10). Fluorescence was subsequently determined using a Perkin Elmer spectro¯uorimeter.
Electrophysiological methods
Virtually solvent-free planar lipid bilayers were formed by the method of Montal and Mueller (1972) by the apposition of two monolayers on a 125 mm-é hole in a 10 mM Te¯on ®lm pre-treated with hexadecane/hexane (1 : 40, v : v) . Monolayers were generated using a lipid mixture PalmitoylOleoyPhosphatidylCholine/DioleoylPhosphatidylEthanolamine (POPC/ DOPE; 7 : 3; w : w) supplemented with 3% cardiolipin (Avanti, Birmingham, USA) and dissolved in hexane (0.5%, w : v). The electrolyte solution was 0.1 M KCl, 10 mM N-2-hydroxyethylpiperazine-N'-2 ethanesulfonic acid [HEPES], 1 mM MgCl 2 (pH 7.4), in both compartments. ANT (1 nM, pre-incubated 30 min or not with 10 mM BA), Bax (0.3 nM), Bid and t-Bid (0.1 nM) were added sequentially to the same compartment. Membrane currents under applied voltage were measured using a BLM 120 ampli®er (Biologic) and Ag/AgCl electrodes. The current¯uctuations were stored on a DTR 1202 (Biologic) and were analysed using software from Intracel. Since the system was voltage-independent, experiments were realized at dierent voltages and conductance values were expressed by the ratio I/V. Abbreviations AIF, apoptosis-inducing factor; ANT, adenine nucleotide translocator; Atr, atractyloside; BA, bongkrekic acid; CsA, cyclosporin A; Cyt-c, cytochrome c, mod. CsA, N-methyl-4-Val-cyclosporin A; IM, inner membrane; MMP, mitochondrial membrane permeabilization; 4-MU, 4-methylumbelliferone; 4-MUP, 4-methylumbelliferylphosphate; OM, outer membrane; PTPC, permeability transition pore complex; PA, KoÈ nig's polyanion; t-Bid, truncated Bid; VDAC, voltage dependent anion channel.
